Skip to Main Content

Paper Details

TGF-β signaling proteins and CYP24A1 may serve as surrogate markers for progesterone calcitriol treatment in ovarian and endometrial cancers of different histological types.
Transl Cancer Res
5
2019
Author NameAffiliation
Yovanni CasablancaUniformed Services University of the Health Sciences
Yovanni CasablancaGynecologic Cancer Center of Excellence, Uniformed Services University of the Health Sciences and Walter Reed National Military Medical Center
Yovanni CasablancaJohn P. Murtha Cancer Center, Uniformed Services University of the Health Sciences and Walter Reed National Military Medical Center
Gustavo C RodriguezNorthShore University HealthSystem, University of Chicago
George L MaxwellGynecologic Cancer Center of Excellence, Uniformed Services University of the Health Sciences and Walter Reed National Military Medical Center
George L MaxwellJohn P. Murtha Cancer Center, Uniformed Services University of the Health Sciences and Walter Reed National Military Medical Center
George L MaxwellInova Fairfax Hospital
Kathleen M DarcyGynecologic Cancer Center of Excellence, Uniformed Services University of the Health Sciences and Walter Reed National Military Medical Center
Kathleen M DarcyJohn P. Murtha Cancer Center, Uniformed Services University of the Health Sciences and Walter Reed National Military Medical Center
Kathleen M DarcyInova Schar Cancer Institute, Inova Center for Personalized Health
  • 1 - 10

Datasets